Your browser doesn't support javascript.
loading
miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker.
Li, Feng; Wang, Feiran; Zhu, Changlai; Wei, Qun; Zhang, Tianyi; Zhou, You Lang.
Afiliación
  • Li F; Department of Gastroenterology.
  • Wang F; Department of General Surgery, Affiliated Hospital of Nantong University.
  • Zhu C; Key Laboratory of Neuroregeneration, Nantong University.
  • Wei Q; Department of Gastroenterology.
  • Zhang T; Department of Gastroenterology.
  • Zhou YL; The Hand Surgery Research Center, Department of Hand Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People's Republic of China.
Int J Nanomedicine ; 13: 2295-2307, 2018.
Article en En | MEDLINE | ID: mdl-29713162

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Genética / Biomarcadores de Tumor / Carcinoma Hepatocelular / MicroARNs / Nanopartículas / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Nanomedicine Año: 2018 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Genética / Biomarcadores de Tumor / Carcinoma Hepatocelular / MicroARNs / Nanopartículas / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Nanomedicine Año: 2018 Tipo del documento: Article Pais de publicación: Nueva Zelanda